M41L/D67N/L210W/T215Y/A360V |
mutation decreases efficiency of RNase H cleavage and increases excision of AZT in the presence of the pyrophosphate donor ATP |
Human immunodeficiency virus 1 |
M41L/D67N/L210W/T215Y/A360V/N348I/E478Q |
mutation decreases efficiency of RNase H cleavage and increases excision of AZT in the presence of the pyrophosphate donor ATP |
Human immunodeficiency virus 1 |
M41L/D67N/L210W/T215Y/E478Q |
mutation decreases efficiency of RNase H cleavage and increases excision of AZT in the presence of the pyrophosphate donor ATP |
Human immunodeficiency virus 1 |
M41L/D67N/L210W/T215Y/N348I |
mutation decreases efficiency of RNase H cleavage and increases excision of AZT in the presence of the pyrophosphate donor ATP |
Human immunodeficiency virus 1 |
M41L/D67N/L210W/T215Y/N348I/A360V |
mutant accumulates transiently formed, shorter hybrids that can rebind to reverse transcriptase before the template is irreversibly degraded |
Human immunodeficiency virus 1 |
additional information |
TAMs refers to mutants that contain the following amino acid substitutions M41L/D67N/L210W/T215Y. Thymidine analogue-associated mutations (TAMs) in reverse transcriptase cause resistance to 3'-azido-3'-deoxythymidine (AZT) through excision of the incorporated monophosphate |
Human immunodeficiency virus 1 |